Spectral Medical Inc. (TSX:EDT)

Spectral Medical Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.87	4.07	2.99	2.95	8.41	8.89
Short-Term Investments	-	0.59	0.59	0.61	0.24	0.72
Cash & Short-Term Investments	0.87	4.66	3.57	3.56	8.66	9.61
Cash Growth	-85.25%	30.30%	0.39%	-58.87%	-9.91%	59.08%
Accounts Receivable	0.2	0.21	0.3	0.05	0.86	0.11
Other Receivables	-	-	0.15	0.14	0.19	0.1
Receivables	0.2	0.21	0.45	0.19	1.06	0.21
Inventory	0.56	0.38	0.23	0.37	0.34	0.29
Prepaid Expenses	0.71	0.05	0.2	0.01	0.04	0.16
Total Current Assets	2.35	5.29	4.46	4.13	10.09	10.26
Property, Plant & Equipment	0.33	0.47	0.69	0.89	0.7	1.06
Long-Term Investments	-	-	-	-	1	-
Other Intangible Assets	0.29	0.33	0.18	0.19	0.21	0.23
Total Assets	2.97	6.1	5.32	5.21	12	11.56

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.11	1.34	0.99	1.6	1.65	0.44
Accrued Expenses	-	1.15	1.78	1.22	1.44	1.08
Current Portion of Long-Term Debt	19.5	16.44	14.43	7.94	0.08	-
Current Portion of Leases	0.14	0.14	0.13	0.12	0.1	0.09
Current Unearned Revenue	0.43	0.69	0.38	0.73	0.7	0.69
Other Current Liabilities	31.25	46.52	9.74	6.31	2.67	-
Total Current Liabilities	54.43	66.27	27.45	17.92	6.63	2.3
Long-Term Debt	6.64	4.29	-	-	3.49	-
Long-Term Leases	0.13	0.24	0.37	0.5	0.42	0.49
Long-Term Unearned Revenue	4.2	4.56	5.05	3.34	4.01	4.68
Other Long-Term Liabilities	1.25	0.47	-	-	-	-
Total Liabilities	66.65	75.82	32.87	21.76	14.55	7.47

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	98.47	95.93	90.57	87.06	87.05	84.36
Additional Paid-In Capital	10.22	10.22	10.15	8.92	8.77	7.99
Retained Earnings	-186.04	-188.53	-140.84	-125.44	-109.78	-98.49
Comprehensive Income & Other	13.67	12.66	12.58	12.91	11.4	10.24
Shareholders' Equity	-63.68	-69.72	-27.55	-16.55	-2.55	4.08
Total Liabilities & Equity	2.97	6.1	5.32	5.21	12	11.56

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	26.41	21.09	14.93	8.56	4.08	0.58
Net Cash (Debt)	-25.54	-16.43	-11.35	-5	4.57	9.03
Net Cash Growth	-	-	-	-	-49.33%	68.00%
Net Cash Per Share	-0.10	-0.06	-0.04	-0.02	0.02	0.04
Filing Date Shares Outstanding	254.95	293.42	285.12	279.39	278.55	268.14
Total Common Shares Outstanding	254.95	292.56	284.32	278.58	278.55	267.89
Working Capital	-52.08	-60.98	-22.99	-13.79	3.45	7.96
Book Value Per Share	-0.25	-0.24	-0.10	-0.06	-0.01	0.02
Tangible Book Value	-63.98	-70.06	-27.72	-16.74	-2.77	3.86
Tangible Book Value Per Share	-0.25	-0.24	-0.10	-0.06	-0.01	0.01
Machinery	-	2.82	2.82	2.79	2.66	3.09
Leasehold Improvements	-	0.39	0.39	0.39	0.34	0.33

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error